Phapros Tbk PT (PEHA)

Currency in IDR
340
0(0.00%)
Closed·
PEHA Scorecard
Full Analysis
High shareholder yield
PEHA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
338350
52 wk Range
260424
Key Statistics
Bid/Ask
338.00 / 340.00
Prev. Close
340
Open
340
Day's Range
338-350
52 wk Range
260-424
Volume
99K
Average Volume (3m)
463.92K
1-Year Change
-1.16%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PEHA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Phapros Tbk PT Company Profile

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, X-Gra, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.

Employees
1233
Market
Indonesia

Compare PEHA to Peers and Sector

Metrics to compare
PEHA
Peers
Sector
Relationship
P/E Ratio
−1.2x−0.2x−0.5x
PEG Ratio
0.000.050.00
Price/Book
0.7x1.4x2.6x
Price / LTM Sales
0.3x1.8x3.3x
Upside (Analyst Target)
-−41.2%43.5%
Fair Value Upside
Unlock−7.7%6.9%Unlock

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
10.85 / --
Revenue / Forecast
257.56B / --
EPS Revisions
Last 90 days

PEHA Income Statement

People Also Watch

458
BRMS
-2.14%
1,670
DVLA
-1.18%
635
ENRG
+4.96%
880
HRUM
+1.15%

FAQ

What Stock Exchange Does Phapros Trade On?

Phapros is listed and trades on the Jakarta Stock Exchange stock exchange.

What Is the Stock Symbol for Phapros?

The stock symbol for Phapros is "PEHA."

What Is the Phapros Market Cap?

As of today, Phapros market cap is 285.60B.

What Is Phapros's Earnings Per Share (TTM)?

The Phapros EPS (TTM) is -277.65.

From a Technical Analysis Perspective, Is PEHA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Phapros Stock Split?

Phapros has split 0 times.

How Many Employees Does Phapros Have?

Phapros has 1233 employees.

What is the current trading status of Phapros (PEHA)?

As of 07 Aug 2025, Phapros (PEHA) is trading at a price of 340.00, with a previous close of 340.00. The stock has fluctuated within a day range of 338.00 to 350.00, while its 52-week range spans from 260.00 to 424.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.